GE HealthCare Technologies Inc. $GEHC Stock: Wellington Grp LLC Boosts Holdings

Wellington Grp LLC raised its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 68.9% during the 3rd quarter, Holdings Channel.com reports. The firm owned 19,890 shares of the company’s stock after acquiring an additional 8,115 shares during the period. Wellington Grp LLC’s holdings in GE HealthCare Technologies were worth $1,300,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Chicago Partners Investment Group LLC grew its position in GE HealthCare Technologies by 1.9% during the 3rd quarter. Chicago Partners Investment Group LLC now owns 7,246 shares of the company’s stock worth $518,000 after purchasing an additional 133 shares during the period. Carnegie Investment Counsel lifted its holdings in shares of GE HealthCare Technologies by 2.0% in the 3rd quarter. Carnegie Investment Counsel now owns 7,678 shares of the company’s stock valued at $502,000 after buying an additional 151 shares during the period. Valeo Financial Advisors LLC lifted its holdings in shares of GE HealthCare Technologies by 3.5% in the 3rd quarter. Valeo Financial Advisors LLC now owns 4,850 shares of the company’s stock valued at $317,000 after buying an additional 163 shares during the period. Yousif Capital Management LLC lifted its holdings in shares of GE HealthCare Technologies by 0.4% in the 3rd quarter. Yousif Capital Management LLC now owns 46,991 shares of the company’s stock valued at $3,072,000 after buying an additional 167 shares during the period. Finally, Sigma Planning Corp boosted its stake in shares of GE HealthCare Technologies by 3.6% in the third quarter. Sigma Planning Corp now owns 5,152 shares of the company’s stock worth $337,000 after buying an additional 178 shares during the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Price Performance

GEHC opened at $83.02 on Monday. GE HealthCare Technologies Inc. has a fifty-two week low of $58.75 and a fifty-two week high of $89.77. The company has a debt-to-equity ratio of 0.86, a quick ratio of 1.01 and a current ratio of 1.30. The company has a fifty day moving average of $70.55 and a two-hundred day moving average of $70.11. The stock has a market capitalization of $37.54 billion, a price-to-earnings ratio of 17.51, a PEG ratio of 2.09 and a beta of 0.65.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last issued its quarterly earnings data on Wednesday, October 28th. The company reported $1.34 earnings per share for the quarter, topping analysts’ consensus estimates of $1.20 by $0.14. GE HealthCare Technologies had a net margin of 9.96% and a return on equity of 20.45%. The business had revenue of $5.51 billion during the quarter, compared to the consensus estimate of $5.35 billion. During the same quarter in the prior year, the firm posted $1.07 earnings per share. The company’s revenue was up 7.2% compared to the same quarter last year. On average, research analysts expect that GE HealthCare Technologies Inc. will post 5.02 earnings per share for the current year.

GE HealthCare Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 13th. Investors of record on Friday, October 23rd were paid a $0.04 dividend. The ex-dividend date was Friday, October 23rd. This represents a $0.16 annualized dividend and a dividend yield of 0.2%. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.38%.

Analyst Ratings Changes

GEHC has been the topic of several analyst reports. Bank of America reaffirmed a “neutral” rating on shares of GE HealthCare Technologies in a report on Thursday, October 29th. Royal Bank Of Canada lifted their price target on GE HealthCare Technologies from $80.00 to $90.00 and gave the company an “outperform” rating in a research report on Thursday, October 29th. Wolfe Research initiated coverage on GE HealthCare Technologies in a report on Tuesday, October 20th. They issued a “peer perform” rating for the company. Wells Fargo & Company boosted their price target on GE HealthCare Technologies from $75.00 to $85.00 and gave the company an “overweight” rating in a report on Thursday, July 30th. Finally, Zacks Research upgraded GE HealthCare Technologies from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 11th. Twelve investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $82.17.

Get Our Latest Report on GE HealthCare Technologies

About GE HealthCare Technologies

(Free Report)

GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.

Read More

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.